COMPANY
NOVO NORDISK AS
NOVO NORDISK AS: marketing authorisation holder for Glucagon, Insulin degludec, Liraglutide, Semaglutide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Glucagon | GLUCAGEN HYPOKIT 1 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, PL 04668/0027, Authorised Regulator MHRA |
|---|---|
| Insulin degludec | TRESIBA 100 UNITS/ML SOLUTION FOR INJECTION IN CARTRIDGE, PLGB 04668/0411, Authorised Regulator MHRA |
| Insulin degludec | TRESIBA 200 UNITS/ML SOLUTION FOR INJECTION IN PRE FILLED PEN, PLGB 04668/0412, Authorised Regulator MHRA |
| Insulin degludec | XULTOPHY 100 UNITS/ML + 3.6 MG/ML SOLUTION FOR INJECTION, PLGB 04668/0414, Authorised Regulator MHRA |
| Liraglutide | SAXENDA 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0409, Authorised Regulator MHRA |
| Semaglutide | OZEMPIC 0.25 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0331, Authorised Regulator MHRA |
| Semaglutide | OZEMPIC 0.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0332, Authorised Regulator MHRA |
| Semaglutide | OZEMPIC 1 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0333, Authorised Regulator MHRA |
| Semaglutide | OZEMPIC 2MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0435, Authorised Regulator MHRA |
| Semaglutide | RYBELSUS 1.5 MG TABLETS, PLGB 04668/0451, Authorised Regulator MHRA |
| Semaglutide | RYBELSUS 14 MG TABLETS, PLGB 04668/0422, Authorised Regulator MHRA |
| Semaglutide | RYBELSUS 3 MG TABLETS, PLGB 04668/0420, Authorised Regulator MHRA |
| Semaglutide | RYBELSUS 4 MG TABLETS, PLGB 04668/0452, Authorised Regulator MHRA |
| Semaglutide | RYBELSUS 7 MG TABLETS, PLGB 04668/0421, Authorised Regulator MHRA |
| Semaglutide | RYBELSUS 9 MG TABLETS, PLGB 04668/0453, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 0.25 MG FLEXTOUCH, SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0436, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 0.5 MG FLEXTOUCH, SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0437, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 1 MG FLEXTOUCH, SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0438, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 1.5 MG TABLETS, PL 04668/0466, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 1.7 MG FLEXTOUCH, SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0439, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 2.4 MG FLEXTOUCH, SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0440, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 25 MG TABLETS, PL 04668/0469, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 4 MG TABLETS, PL 04668/0467, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 7.2 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 04668/0460, Authorised Regulator MHRA |
| Semaglutide | WEGOVY 9 MG TABLETS, PL 04668/0468, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.